165 related articles for article (PubMed ID: 37794242)
1. Serum irisin levels are negatively associated with blood pressure in dialysis patients.
Wang PX; Fan ZJ; Wu LY; Wang SY; Zhang JL; Dong XT; Zhang AH
Hypertens Res; 2023 Dec; 46(12):2738-2745. PubMed ID: 37794242
[TBL] [Abstract][Full Text] [Related]
2. Serum irisin levels correlated to peritoneal dialysis adequacy in nondiabetic peritoneal dialysis patients.
Tan Z; Ye Z; Zhang J; Chen Y; Cheng C; Wang C; Liu X; Lou T; Peng H
PLoS One; 2017; 12(4):e0176137. PubMed ID: 28445520
[TBL] [Abstract][Full Text] [Related]
3. Serum irisin level is higher in peritoneal dialysis than in hemodialysis.
Song XY; Zhou SJ; Zhang JL; Zhou T; Wang SY; Pang Q; Pan YJ; Zhang AH
Int Urol Nephrol; 2023 May; 55(5):1329-1334. PubMed ID: 36527594
[TBL] [Abstract][Full Text] [Related]
4. Relationship between Serum Irisin Level, All-Cause Mortality, and Cardiovascular Mortality in Peritoneal Dialysis Patients.
Zhou S; Tang W; Wang X; Han Q; Bai Q; Zhang A
Kidney Blood Press Res; 2024; 49(1):38-47. PubMed ID: 38043511
[TBL] [Abstract][Full Text] [Related]
5. Expressions of irisin and urotensin II and their relationships with blood pressure in patients with preeclampsia.
Zhang LJ; Xie Q; Tang CS; Zhang AH
Clin Exp Hypertens; 2017; 39(5):460-467. PubMed ID: 28534711
[TBL] [Abstract][Full Text] [Related]
6. Irisin, a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients.
Lee MJ; Lee SA; Nam BY; Park S; Lee SH; Ryu HJ; Kwon YE; Kim YL; Park KS; Oh HJ; Park JT; Han SH; Ryu DR; Kang SW; Yoo TH
Atherosclerosis; 2015 Oct; 242(2):476-82. PubMed ID: 26298738
[TBL] [Abstract][Full Text] [Related]
7. Lower Serum Irisin Levels Are Associated with Increased Abdominal Aortic Calcification in Peritoneal Dialysis Patients.
Zhou SJ; Wang XX; Tang W; Han QF; He L; Zhang AH
Kidney Dis (Basel); 2021 May; 7(3):219-226. PubMed ID: 34179117
[TBL] [Abstract][Full Text] [Related]
8. Circulating irisin levels reflect visceral adiposity in non-diabetic patients undergoing hemodialysis.
Yilmaz H; Cakmak M; Darcin T; Inan O; Sahiner E; Demir C; Aktas A; Bilgic MA; Akcay A
Ren Fail; 2016 Jul; 38(6):914-9. PubMed ID: 27089215
[TBL] [Abstract][Full Text] [Related]
9. Circulating serum irisin levels in obesity and type 2 diabetes mellitus.
Shoukry A; Shalaby SM; El-Arabi Bdeer S; Mahmoud AA; Mousa MM; Khalifa A
IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658
[TBL] [Abstract][Full Text] [Related]
10. Circulating Adipocyte Fatty Acid Binding Protein (FABP4) Levels Are Associated with Irisin in the Middle-Aged General Chinese Population.
Zhang S; Yang L; Chen P; Jin H; Xie X; Yang M; Gao T; Hu C; Yu X
PLoS One; 2016; 11(1):e0146605. PubMed ID: 26752184
[TBL] [Abstract][Full Text] [Related]
11. Maternal serum and fetal cord blood irisin levels in gestational diabetes mellitus.
Yuksel MA; Oncul M; Tuten A; Imamoglu M; Acikgoz AS; Kucur M; Madazli R
Diabetes Res Clin Pract; 2014 Apr; 104(1):171-5. PubMed ID: 24447809
[TBL] [Abstract][Full Text] [Related]
12. Lower Serum Irisin Levels Are Associated with Increased Vascular Calcification in Hemodialysis Patients.
He L; He WY; A LT; Yang WL; Zhang AH
Kidney Blood Press Res; 2018; 43(1):287-295. PubMed ID: 29490308
[TBL] [Abstract][Full Text] [Related]
13. Association of serum concentrations of irisin and the adipokines adiponectin and leptin with epicardial fat in cardiovascular surgery patients.
Kaneda H; Nakajima T; Haruyama A; Shibasaki I; Hasegawa T; Sawaguchi T; Kuwata T; Obi S; Arikawa T; Sakuma M; Amano H; Toyoda S; Fukuda H; Inoue T
PLoS One; 2018; 13(8):e0201499. PubMed ID: 30071056
[TBL] [Abstract][Full Text] [Related]
14. Association of metabolic parameters and rs726344 in FNDC5 with serum irisin concentrations.
Ebert T; Kralisch S; Wurst U; Scholz M; Stumvoll M; Kovacs P; Fasshauer M; Tönjes A
Int J Obes (Lond); 2016 Feb; 40(2):260-5. PubMed ID: 26285604
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of the myokine irisin in relation to metabolic and renal function.
Ebert T; Focke D; Petroff D; Wurst U; Richter J; Bachmann A; Lössner U; Kralisch S; Kratzsch J; Beige J; Bast I; Anders M; Blüher M; Stumvoll M; Fasshauer M
Eur J Endocrinol; 2014 Apr; 170(4):501-6. PubMed ID: 24399249
[TBL] [Abstract][Full Text] [Related]
16. The association of circulating irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study.
Tang L; Tong Y; Zhang F; Chen G; Zhang YC; Jobin J; Tong N
BMC Endocr Disord; 2019 Dec; 19(1):147. PubMed ID: 31881940
[TBL] [Abstract][Full Text] [Related]
17. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.
Huh JY; Panagiotou G; Mougios V; Brinkoetter M; Vamvini MT; Schneider BE; Mantzoros CS
Metabolism; 2012 Dec; 61(12):1725-38. PubMed ID: 23018146
[TBL] [Abstract][Full Text] [Related]
18. Cardiometabolic Effects of Irisin in Patients with End-Stage Renal Disease on Regular Hemo- or Peritoneal Dialysis.
Csiky B; Sági B; Emmert V; Wittmann I; Sulyok E
Blood Purif; 2022; 51(5):450-457. PubMed ID: 34350871
[TBL] [Abstract][Full Text] [Related]
19. Association of irisin and FNDC5 rs16835198 G>T gene polymorphism with type 2 diabetes mellitus and diabetic nephropathy. An Egyptian pilot study.
Khidr EG; Ali SS; Elshafey MM; Fawzy OA
Gene; 2017 Aug; 626():26-31. PubMed ID: 28479383
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Irisin on Nω-Nitro-L-arginine Methyl Ester Hydrochloride-Induced Hypertension in Rats.
Aydoğdu N; Yalçınkaya Yavuz Ö; Taştekin E; Tayfur P; Kaya O; Kandemir N
Balkan Med J; 2019 Oct; 36(6):337-346. PubMed ID: 31486326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
